HK1202813A1 - 用於預防或治療雄激素介導的疾病的孕酮受體調節劑 - Google Patents
用於預防或治療雄激素介導的疾病的孕酮受體調節劑Info
- Publication number
- HK1202813A1 HK1202813A1 HK15103497.5A HK15103497A HK1202813A1 HK 1202813 A1 HK1202813 A1 HK 1202813A1 HK 15103497 A HK15103497 A HK 15103497A HK 1202813 A1 HK1202813 A1 HK 1202813A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preventing
- receptor modulators
- mediated diseases
- progesterone receptor
- treating androgen
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000002379 progesterone receptor modulator Substances 0.000 title 1
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12168319.7A EP2664325A1 (en) | 2012-05-16 | 2012-05-16 | Methods for preventing or treating androgen mediated diseases |
| PCT/IB2013/053959 WO2013171684A1 (en) | 2012-05-16 | 2013-05-15 | Progesterone receptor modulators for use in preventing or treating androgen mediated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1202813A1 true HK1202813A1 (zh) | 2015-10-09 |
Family
ID=48699889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15103497.5A HK1202813A1 (zh) | 2012-05-16 | 2015-04-09 | 用於預防或治療雄激素介導的疾病的孕酮受體調節劑 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20150209373A1 (zh) |
| EP (2) | EP2664325A1 (zh) |
| JP (1) | JP2015516461A (zh) |
| KR (1) | KR20150013596A (zh) |
| CN (1) | CN104411302A (zh) |
| AU (1) | AU2013261081A1 (zh) |
| BR (1) | BR112014028629A2 (zh) |
| CA (1) | CA2872233A1 (zh) |
| CO (1) | CO7151508A2 (zh) |
| EA (1) | EA201491939A1 (zh) |
| HK (1) | HK1202813A1 (zh) |
| MX (1) | MX2014013911A (zh) |
| TW (1) | TW201408306A (zh) |
| WO (1) | WO2013171684A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11883675B2 (en) | 2019-12-20 | 2024-01-30 | Medtronic, Inc. | Transcutaneous energy transfer system including alarm |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4039561A1 (de) * | 1990-12-07 | 1992-07-09 | Schering Ag | Verwendung von antigestagenen zur herstellung von arzneimitteln |
| CA2668824A1 (en) * | 1996-05-01 | 1997-11-06 | The Government Of The United States Of America, Represented By The Secre Tary Of The Department Of Health And Human Services | 21-substituted progesterone derivatives as new antiprogestational agents |
| DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
| MXPA04012420A (es) * | 2002-06-25 | 2005-04-19 | Wyeth Corp | Derivados de ciclotiocabamativa como moduladores de rp y uso de los mismos para tratamiento de trastornos de la piel. |
| EP1807420B1 (en) * | 2004-10-27 | 2010-03-10 | Janssen Pharmaceutica N.V. | Trisubstituted thiophenes as progesterone receptor modulators |
| US8173626B2 (en) * | 2006-03-08 | 2012-05-08 | Danco Laboratories Llc | Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders |
| EP2400847B1 (en) * | 2009-02-24 | 2014-12-17 | Medivation Prostate Therapeutics, Inc. | Specific diarylthiohydantoin compounds |
-
2012
- 2012-05-16 EP EP12168319.7A patent/EP2664325A1/en not_active Withdrawn
-
2013
- 2013-05-14 TW TW102117047A patent/TW201408306A/zh unknown
- 2013-05-15 EP EP13731928.1A patent/EP2849734A1/en not_active Withdrawn
- 2013-05-15 EA EA201491939A patent/EA201491939A1/ru unknown
- 2013-05-15 US US14/401,287 patent/US20150209373A1/en not_active Abandoned
- 2013-05-15 KR KR1020147033025A patent/KR20150013596A/ko not_active Application Discontinuation
- 2013-05-15 MX MX2014013911A patent/MX2014013911A/es unknown
- 2013-05-15 AU AU2013261081A patent/AU2013261081A1/en not_active Abandoned
- 2013-05-15 CA CA2872233A patent/CA2872233A1/en not_active Abandoned
- 2013-05-15 WO PCT/IB2013/053959 patent/WO2013171684A1/en active Application Filing
- 2013-05-15 BR BR112014028629A patent/BR112014028629A2/pt not_active Application Discontinuation
- 2013-05-15 CN CN201380025583.7A patent/CN104411302A/zh active Pending
- 2013-05-15 JP JP2015512180A patent/JP2015516461A/ja active Pending
-
2014
- 2014-12-02 CO CO14265256A patent/CO7151508A2/es not_active Application Discontinuation
-
2015
- 2015-04-09 HK HK15103497.5A patent/HK1202813A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013261081A1 (en) | 2014-12-04 |
| CN104411302A (zh) | 2015-03-11 |
| US20150209373A1 (en) | 2015-07-30 |
| EP2664325A1 (en) | 2013-11-20 |
| EA201491939A1 (ru) | 2015-02-27 |
| BR112014028629A2 (pt) | 2018-04-24 |
| WO2013171684A1 (en) | 2013-11-21 |
| TW201408306A (zh) | 2014-03-01 |
| KR20150013596A (ko) | 2015-02-05 |
| MX2014013911A (es) | 2015-01-12 |
| CA2872233A1 (en) | 2013-11-21 |
| CO7151508A2 (es) | 2014-12-29 |
| EP2849734A1 (en) | 2015-03-25 |
| JP2015516461A (ja) | 2015-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272687A (en) | Cancer treatment methods using PD-L1 axis binding antagonists and VEGF antagonists | |
| HK1211317A1 (zh) | 用於治療肥胖及相關疾病的 調節劑的細胞特異性遞送 | |
| IL275874A (en) | Therapeutic use of adenovirus | |
| HUE046401T2 (hu) | Berendezés és rendszer foggyökér-kezeléshez | |
| ZA201500069B (en) | Lavatory treatment device | |
| EP2868283A4 (en) | THERAPEUTIC TREATMENT DEVICE | |
| HRP20181623T1 (hr) | Modulatori x receptora jetre (lxr) za liječenje bolesti, poremećaja i stanja kože | |
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| EP2939625A4 (en) | THERAPEUTIC TREATMENT DEVICE | |
| HK1215548A1 (zh) | 用於治療神經變性疾病的方法和組合物 | |
| EP2911660A4 (en) | COMPOSITIONS AND METHODS FOR TREATING STROGEN-RELATED MEDICAL DISORDERS | |
| EP2912033A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-MEDIATED ILLNESSES | |
| EP2806894A4 (en) | METHODS AND COMPOSITIONS FOR THERAPEUTICS | |
| GB2502133B (en) | Treatment or therapeutic apparatus | |
| EP2938391A4 (en) | TRANSDERMAL BUPRENORPHINE COMPOSITIONS WITH DELAYED RELEASE AND METHOD OF USE THEREOF | |
| EP2825209A4 (en) | NEUROFIBROMATOSIS THERAPEUTICS AND SCREENING THEREOF | |
| HK1202813A1 (zh) | 用於預防或治療雄激素介導的疾病的孕酮受體調節劑 | |
| LT2863932T (lt) | Kompozicija, skirta naudoti limfedemos gydymui |